The United States has entered an agreement with drugmaker Moderna Inc to acquire 100 million doses of its potential COVID-19 vaccine for around ...
With the exception of its deal with AstraZeneca, which offered a lower price per drug in exchange for upfront research and development costs, all the deals price COVID-19 vaccines between US$20 to US$42 for a two dose course of treatment.
Moderna's vaccine candidate, mRNA-1273, is one of the few that have already advanced to the final stage of testing and is on track to be completed in September, the company said this month.Moderna's deal with the US only pays out in full if the drugmaker hits certain unspecific timing benchmarks for vaccine delivery.
The United States has advanced purchase agreements with Johnson & Johnson, AstraZeneca Plc, Pfizer Inc and BioNTech SE, and Sanofi SA and GlaxoSmithKline Plc for their respective vaccine candidates.The agreements would lock in more than 500 million doses of COVID-19 vaccine for the US, assuming that the companies involved receive regulatory approval. Some deals also give the United States an option to purchase additional doses.
The US government previously gave Moderna about US$1 billion to fund its research efforts, bringing total US funding to about US$2.5 billion. Other countries, including Japan, the United Kingdom and Canada, have forged similar deals with drugmakers.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
New Zealand records more than 100 days without domestic coronavirus case but warns against complacencyWELLINGTON (REUTERS) - New Zealand marked 100 days without a domestic transmission of the coronavirus on Sunday (Aug 9), but warned against complacency as countries like Vietnam and Australia which once had the virus under control now battle a resurgence in infections.. Read more at straitstimes.com.
Read more »
US's Azar says any US vaccine would be shared once US needs metU.S. Health Secretary Alex Azar said on Monday that any U.S. vaccine or treatment for COVID-19 would be shared fairly with the rest of the world, ...
Read more »
J&J eyes 1 billion doses of potential COVID-19 shot in 2021, weighs challenge trialsBRUSSELS: Johnson & Johnson could produce 1 billion doses of its potential COVID-19 vaccine next year if it proves successful and would consider ...
Read more »
Pre-orders of COVID-19 vaccine top five billionAlthough none of the coronavirus vaccines under development has proved its efficacy yet in clinical trials, at least 5.7 billion doses have been ...
Read more »
Singapore-developed COVID-19 vaccine injected into first group of volunteers in trialThe first group of volunteers have been dosed with an investigative COVID-19 vaccine for an early stage of a Singapore-based trial.
Read more »
Johnson & Johnson eyes 1 billion doses of potential Covid-19 shot in 2021, weighs challenge trialsBRUSSELS (REUTERS) - Johnson & Johnson could produce 1 billion doses of its potential Covid-19 vaccine next year if it proves successful and would consider injecting healthy volunteers with the novel coronavirus if there are not enough patients for final trials, a company executive said.. Read more at straitstimes.com.
Read more »